Anaplastic lymphoma kinase modulators and methods of use

Abstract The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MANALO, JEAN-CLAIRE L, BUSSENIUS, JOERG, KENNEDY, ABIGAIL R, PETO, CSABA J, DUBENKO, LARISA, KHOURY, RICHARD G, CURTIS, JEFFRY KIMO, BLAZEY, CHARLES M, COSTANZO, SIMONA, KIM, ANGIE I, BOWLES, OWEN JOSEPH, ANAND, NEEL KUMAR, RICE, KENNETH D, TSANG, TSZE H
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MANALO, JEAN-CLAIRE L
BUSSENIUS, JOERG
KENNEDY, ABIGAIL R
PETO, CSABA J
DUBENKO, LARISA
KHOURY, RICHARD G
CURTIS, JEFFRY KIMO
BLAZEY, CHARLES M
COSTANZO, SIMONA
KIM, ANGIE I
BOWLES, OWEN JOSEPH
ANAND, NEEL KUMAR
RICE, KENNETH D
TSANG, TSZE H
description Abstract The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2011202643A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2011202643A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2011202643A13</originalsourceid><addsrcrecordid>eNrjZLBwzEssyEksLslMVsipzC3IyM9NVMjOzEssTlXIzU8pzUksyS8qVkjMS1HITS3JyE8pVshPUygtTuVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhoZGBkZmJsaOhsbEqQIA2PMvLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anaplastic lymphoma kinase modulators and methods of use</title><source>esp@cenet</source><creator>MANALO, JEAN-CLAIRE L ; BUSSENIUS, JOERG ; KENNEDY, ABIGAIL R ; PETO, CSABA J ; DUBENKO, LARISA ; KHOURY, RICHARD G ; CURTIS, JEFFRY KIMO ; BLAZEY, CHARLES M ; COSTANZO, SIMONA ; KIM, ANGIE I ; BOWLES, OWEN JOSEPH ; ANAND, NEEL KUMAR ; RICE, KENNETH D ; TSANG, TSZE H</creator><creatorcontrib>MANALO, JEAN-CLAIRE L ; BUSSENIUS, JOERG ; KENNEDY, ABIGAIL R ; PETO, CSABA J ; DUBENKO, LARISA ; KHOURY, RICHARD G ; CURTIS, JEFFRY KIMO ; BLAZEY, CHARLES M ; COSTANZO, SIMONA ; KIM, ANGIE I ; BOWLES, OWEN JOSEPH ; ANAND, NEEL KUMAR ; RICE, KENNETH D ; TSANG, TSZE H</creatorcontrib><description>Abstract The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110623&amp;DB=EPODOC&amp;CC=AU&amp;NR=2011202643A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110623&amp;DB=EPODOC&amp;CC=AU&amp;NR=2011202643A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MANALO, JEAN-CLAIRE L</creatorcontrib><creatorcontrib>BUSSENIUS, JOERG</creatorcontrib><creatorcontrib>KENNEDY, ABIGAIL R</creatorcontrib><creatorcontrib>PETO, CSABA J</creatorcontrib><creatorcontrib>DUBENKO, LARISA</creatorcontrib><creatorcontrib>KHOURY, RICHARD G</creatorcontrib><creatorcontrib>CURTIS, JEFFRY KIMO</creatorcontrib><creatorcontrib>BLAZEY, CHARLES M</creatorcontrib><creatorcontrib>COSTANZO, SIMONA</creatorcontrib><creatorcontrib>KIM, ANGIE I</creatorcontrib><creatorcontrib>BOWLES, OWEN JOSEPH</creatorcontrib><creatorcontrib>ANAND, NEEL KUMAR</creatorcontrib><creatorcontrib>RICE, KENNETH D</creatorcontrib><creatorcontrib>TSANG, TSZE H</creatorcontrib><title>Anaplastic lymphoma kinase modulators and methods of use</title><description>Abstract The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwzEssyEksLslMVsipzC3IyM9NVMjOzEssTlXIzU8pzUksyS8qVkjMS1HITS3JyE8pVshPUygtTuVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhoZGBkZmJsaOhsbEqQIA2PMvLg</recordid><startdate>20110623</startdate><enddate>20110623</enddate><creator>MANALO, JEAN-CLAIRE L</creator><creator>BUSSENIUS, JOERG</creator><creator>KENNEDY, ABIGAIL R</creator><creator>PETO, CSABA J</creator><creator>DUBENKO, LARISA</creator><creator>KHOURY, RICHARD G</creator><creator>CURTIS, JEFFRY KIMO</creator><creator>BLAZEY, CHARLES M</creator><creator>COSTANZO, SIMONA</creator><creator>KIM, ANGIE I</creator><creator>BOWLES, OWEN JOSEPH</creator><creator>ANAND, NEEL KUMAR</creator><creator>RICE, KENNETH D</creator><creator>TSANG, TSZE H</creator><scope>EVB</scope></search><sort><creationdate>20110623</creationdate><title>Anaplastic lymphoma kinase modulators and methods of use</title><author>MANALO, JEAN-CLAIRE L ; BUSSENIUS, JOERG ; KENNEDY, ABIGAIL R ; PETO, CSABA J ; DUBENKO, LARISA ; KHOURY, RICHARD G ; CURTIS, JEFFRY KIMO ; BLAZEY, CHARLES M ; COSTANZO, SIMONA ; KIM, ANGIE I ; BOWLES, OWEN JOSEPH ; ANAND, NEEL KUMAR ; RICE, KENNETH D ; TSANG, TSZE H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2011202643A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MANALO, JEAN-CLAIRE L</creatorcontrib><creatorcontrib>BUSSENIUS, JOERG</creatorcontrib><creatorcontrib>KENNEDY, ABIGAIL R</creatorcontrib><creatorcontrib>PETO, CSABA J</creatorcontrib><creatorcontrib>DUBENKO, LARISA</creatorcontrib><creatorcontrib>KHOURY, RICHARD G</creatorcontrib><creatorcontrib>CURTIS, JEFFRY KIMO</creatorcontrib><creatorcontrib>BLAZEY, CHARLES M</creatorcontrib><creatorcontrib>COSTANZO, SIMONA</creatorcontrib><creatorcontrib>KIM, ANGIE I</creatorcontrib><creatorcontrib>BOWLES, OWEN JOSEPH</creatorcontrib><creatorcontrib>ANAND, NEEL KUMAR</creatorcontrib><creatorcontrib>RICE, KENNETH D</creatorcontrib><creatorcontrib>TSANG, TSZE H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MANALO, JEAN-CLAIRE L</au><au>BUSSENIUS, JOERG</au><au>KENNEDY, ABIGAIL R</au><au>PETO, CSABA J</au><au>DUBENKO, LARISA</au><au>KHOURY, RICHARD G</au><au>CURTIS, JEFFRY KIMO</au><au>BLAZEY, CHARLES M</au><au>COSTANZO, SIMONA</au><au>KIM, ANGIE I</au><au>BOWLES, OWEN JOSEPH</au><au>ANAND, NEEL KUMAR</au><au>RICE, KENNETH D</au><au>TSANG, TSZE H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anaplastic lymphoma kinase modulators and methods of use</title><date>2011-06-23</date><risdate>2011</risdate><abstract>Abstract The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2011202643A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Anaplastic lymphoma kinase modulators and methods of use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A40%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MANALO,%20JEAN-CLAIRE%20L&rft.date=2011-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2011202643A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true